Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425562
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-04-30
Brief Title:
The Potential Added Value of Impulse Oscillometry in Asthma Monitoring
Sponsor:
Universitair Ziekenhuis Brussel
Organization:
Universitair Ziekenhuis Brussel
Study Overview
Official Title:
The Potential Added Value of Impulse Oscillometry in Asthma Monitoring
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AM-IOS
Brief Summary:
The goal of this longitudinal observational study is to learn if impulse oscillometry IOS has an added value in asthma monitoring in adult asthma patients who are prescribed a change in asthma maintenance therapy The main questions it aims to answer are
Is there a difference in the change in IOS parameters and FEV1 respectively stratified according to change in asthma control test
Is there a difference in the change in IOS parameters and FEV1 respectively stratified according to change in other questionnaire such as the asthma control questionnaire and the asthma quality of life questionnaire
Are the proposed minimal clinically important differences MCIDs valid for short follow-up periods 3 - 6 months
Participants will undergo lung function testing full lung function multiple breath nitrogen washout impulse oscillometry and questionnaires asthma control test asthma control questionnaire asthma quality of life questionnaire once during the baseline visit and once during the follow-up visit three to six months later
Is there a difference in the change in IOS parameters and FEV1 respectively stratified according to change in asthma control test
Is there a difference in the change in IOS parameters and FEV1 respectively stratified according to change in other questionnaire such as the asthma control questionnaire and the asthma quality of life questionnaire
Are the proposed minimal clinically important differences MCIDs valid for short follow-up periods 3 - 6 months
Participants will undergo lung function testing full lung function multiple breath nitrogen washout impulse oscillometry and questionnaires asthma control test asthma control questionnaire asthma quality of life questionnaire once during the baseline visit and once during the follow-up visit three to six months later
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None